A Bayesian Disease Progression Model for Clinical Trajectories

  • Yingying ZhuEmail author
  • Mert R. SabuncuEmail author
Conference paper
Part of the Lecture Notes in Computer Science book series (LNCS, volume 11044)


In this work, we consider the problem of predicting the course of a progressive disease, such as cancer or Alzheimer’s. Progressive diseases often start with mild symptoms that might precede a diagnosis, and each patient follows their own trajectory. Patient trajectories exhibit wild variability, which can be associated with many factors such as genotype, age, or sex. An additional layer of complexity is that, in real life, the amount and type of data available for each patient can differ significantly. For example, for one patient we might have no prior history, whereas for another patient we might have detailed clinical assessments obtained at multiple prior time-points. This paper presents a probabilistic model that can handle multiple modalities (including images and clinical assessments) and variable patient histories with irregular timings and missing entries, to predict clinical scores at future time-points. We use a sigmoidal function to model latent disease progression, which gives rise to clinical observations in our generative model. We implemented an approximate Bayesian inference strategy on the proposed model to estimate the parameters on data from a large population of subjects. Furthermore, the Bayesian framework enables the model to automatically fine-tune its predictions based on historical observations that might be available on the test subject. We applied our method to a longitudinal Alzheimer’s disease dataset with more than 3,000 subjects [1] with comparisons against several benchmarks.



This work was supported by NIH grants R01LM012719, R01AG053949, and 1R21AG050122, and the NSF NeuroNex grant 1707312. We used data from Tadpole 2017 Challenge (


  1. 1.
    Petersen, R.: Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74, 201–209 (2010)CrossRefGoogle Scholar
  2. 2.
    Alzheimer’s Association: Alzheimer’s disease facts and figures. Alzheimer’s Dement. 158–194 (2010)Google Scholar
  3. 3.
    Jack, C., et al.: Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 9, 119–128 (2010)CrossRefGoogle Scholar
  4. 4.
    Dalca, A.V., Sridharan, R., Sabuncu, M.R., Golland, P.: Predictive modeling of anatomy with genetic and clinical data. In: Navab, N., Hornegger, J., Wells, W.M., Frangi, A.F. (eds.) MICCAI 2015 Part III. LNCS, vol. 9351, pp. 519–526. Springer, Cham (2015). Scholar
  5. 5.
    Haxby, J., Raffaele, K., Gillette, J., Schapiro, M., Rapoport, S.: Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 14(4), 575–592 (1992)CrossRefGoogle Scholar
  6. 6.
    Marta, M.: Modelling mini mental state examination changes in Alzheimer’s disease (2000)Google Scholar
  7. 7.
    Cano, S.J., et al.: The ADAS-COG in Alzheimer’s disease clinical trials: psychometric evaluation of the sum and its parts. J. Neurol. Neurosurg. Psychiat. 81, 1363–1368 (2010)CrossRefGoogle Scholar
  8. 8.
    O’Bryant, S., et al.: Staging dementia using clinical dementia rating scale sum of boxes scores: a Texas Alzheimer’s research consortium study. Archiv. Neurol. 65, 1091–1095 (2008)CrossRefGoogle Scholar
  9. 9.
    Corder, E.H., et al.: Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123), 921–923 (1993)CrossRefGoogle Scholar
  10. 10.
    Katzman, R.: Education and the prevalence of dementia and Alzheimer’s disease. Neurology 43, 13–20 (1993)CrossRefGoogle Scholar
  11. 11.
    Fratiglioni, L., et al.: Prevalence of Alzheimer’s disease and other dementias in an elderly urban population relationship with age, sex, and education. Neurology 41, 1886–1892 (1991)CrossRefGoogle Scholar
  12. 12.
    Jack, C., et al.: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397–1403 (1999)CrossRefGoogle Scholar
  13. 13.
    Nestor, S., et al.: Ventricular enlargement as a possible measure of Alzheimer’s disease progression validated using the Alzheimer’s disease neuroimaging initiative database. Brain 131, 2443–2454 (2008)CrossRefGoogle Scholar
  14. 14.
    Stern, Y.: Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 11(11), 1006–1012 (2012)CrossRefGoogle Scholar
  15. 15.
    Ranganath, R., et al.: Black box variational inference. In: Artificial Intelligence and Statistics (2014)Google Scholar
  16. 16.
    Fischl, B.: FreeSurfer. Neuroimage 62, 774–781 (2012)CrossRefGoogle Scholar
  17. 17.
    Mormino, E., et al.: Polygenic risk of Alzheimer disease is associated with early-and late-life processes. Neurology 87, 481–488 (2016)CrossRefGoogle Scholar
  18. 18.
    Tran, D., et al.: Edward: a library for probabilistic modeling, inference, and criticism. arXiv preprint arXiv:1610.09787 (2016)
  19. 19.
    Abadi, M., et al.: TensorFlow: a system for large-scale machine learning. In: OSDI (2016)Google Scholar
  20. 20.
    Che, Z., Purushotham, S., Cho, K., Sontag, D.A., Liu, Y.: Recurrent neural networks for multivariate time series with missing values. Sci. Rep. 8 (2018)Google Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Schools of ECE and BMECornell UniversityIthacaUSA

Personalised recommendations